Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04720131
Status:
COMPLETED
Last Update Posted:
2024-01-30
First Post:
2021-01-20
Brief Title:
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer
Sponsor:
Beijing Friendship Hospital
Organization:
Beijing Friendship Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-20
First Submit QC Date:
January 20 2021
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-28
Last Update Post Date:
2024-01-30
Last Update Post Date Type:
ACTUAL